Department of Gastroenterology and Hepatology, Graduate School of Medicine, Osaka University, 2-2, K1, Yamada-oka, Suita, Osaka, 565-0871, Japan.
J Gastroenterol. 2010 Jul;45(7):742-9. doi: 10.1007/s00535-010-0205-9. Epub 2010 Feb 13.
Adiponectin is recognized as an antiinflammatory and antifibrotic protein derived from adipocytes, and low serum adiponectin levels are present in obesity. Recent studies have highlighted the relationship between obesity and pancreatic diseases. However, the role of adiponectin in chronic pancreatitis remains uncertain. The aim of this study was to determine the effects of adiponectin in chronic pancreatitis.
We investigated the effects of adiponectin in experimental chronic pancreatitis by using adiponectin-knockout (APN-KO) mice. Chronic pancreatitis was induced by repeated hourly (6 times) intraperitoneal injections of 50 microg/kg cerulein three times per week for 4 weeks in wild-type (WT) and APN-KO mice. We evaluated the severity of chronic pancreatitis biochemically and morphologically.
In cerulein-treated mice, macroscopically and histologically, severe pancreatic damage was observed in APN-KO mice compared with findings in WT mice. The histological scores for chronic pancreatitis, including glandular atrophy, pseudotubular complex, fibrosis, and total scores, were significantly higher in APN-KO mice than in WT mice. Activated pancreatic stellate cells and F4/80-positive pancreatic macrophages accumulated in the pancreas of APN-KO mice but not in WT mice. Overexpression of the mRNAs of transforming growth factor-beta1, CD68, and monocyte chemoattractant protein-1 was noted in APN-KO mice but not in WT mice. The gene expression level of collagen1 (alpha1) tended to be higher in APN-KO mice than in WT mice, albeit insignificantly.
Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice. Hypoadiponectinemia could enhance the severity of chronic pancreatitis.
脂联素是一种源自脂肪细胞的抗炎和抗纤维化蛋白,肥胖患者血清脂联素水平较低。最近的研究强调了肥胖与胰腺疾病之间的关系。然而,脂联素在慢性胰腺炎中的作用仍不确定。本研究旨在确定脂联素在慢性胰腺炎中的作用。
我们通过使用脂联素敲除(APN-KO)小鼠研究了脂联素在实验性慢性胰腺炎中的作用。通过每周 3 次、每次 6 小时、每小时(6 次)腹腔内注射 50μg/kg 亮抑蛋白酶原,在野生型(WT)和 APN-KO 小鼠中诱导慢性胰腺炎,共 4 周。我们从生化和形态学两方面评估慢性胰腺炎的严重程度。
在亮抑蛋白酶原处理的小鼠中,与 WT 小鼠相比,APN-KO 小鼠的胰腺可见严重的宏观和组织学损伤。慢性胰腺炎的组织学评分,包括腺体萎缩、假小管复合体、纤维化和总评分,在 APN-KO 小鼠中明显高于 WT 小鼠。活化的胰腺星状细胞和 F4/80 阳性胰腺巨噬细胞在 APN-KO 小鼠的胰腺中积聚,但在 WT 小鼠中没有。APN-KO 小鼠中转化生长因子-β1、CD68 和单核细胞趋化蛋白-1 的 mRNA 过度表达,但在 WT 小鼠中没有。胶原 1(α1)的基因表达水平在 APN-KO 小鼠中趋于高于 WT 小鼠,但差异无统计学意义。
脂联素缺乏增强了亮抑蛋白酶原诱导的小鼠慢性胰腺炎的严重程度。低脂联素血症可能会加重慢性胰腺炎的严重程度。